Tuesday, February 27, 2007

Company Brief - MBP - Metabolic

Company Brief - MBP - Metabolic

Recent failure (lack of efficacy) at PhII trial sent the share diving to 20c. It was 40c for the past year but spiked at $1.10 early 2007 after news of PhII completion (note though PhII was completed then, the result was not known until now).

Cash about $25m
Shares about 300m
NTA based on cash is about 8.3c per share.

Current price is 2.4 times NTA - still too high.

Watch this stock when price falls below 9c.

No comments: